Obstetrics & Gynaecology · Cervical Carcinoma (Risk Factors, Staging, Treatment)

A 48-year-old woman with Stage IIB cervical cancer completes concurrent chemoradiation with cisplatin. At 3-month follow-up, PET-CT shows a residual 1.5 cm hypermetabolic focus in the cervix with no parametrial extension or distant disease. Which is the most appropriate next step?

  • A Immediate adjuvant hysterectomy
  • B Observation with repeat imaging in 2-3 months to distinguish residual tumor from post-radiation inflammation
  • C Salvage chemoradiation with re-irradiation
  • D Systemic chemotherapy with carboplatin and paclitaxel
Correct answer: B. Observation with repeat imaging in 2-3 months to distinguish residual tumor from post-radiation inflammation

Explanation

Post-treatment PET-CT at 3 months can show false-positive FDG uptake due to radiation-induced inflammation. Current guidelines recommend waiting 2-3 months before concluding residual disease. Adjuvant hysterectomy after chemoradiation does not improve outcomes and increases morbidity. Re-irradiation carries high toxicity. Systemic therapy is reserved for confirmed recurrence or metastatic disease.

Reference: NCCN Guidelines: Cervical Cancer

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Cervical Carcinoma (Risk Factors, Staging, Treatment) MCQs

See all Cervical Carcinoma (Risk Factors, Staging, Treatment) MCQs →